The co-founders of startup Ricursive Intelligence seemed destined to be co-founders. Anna Goldie, CEO, and Azalia Mirhoseini, CTO, are so well-known in the AI community that they were among those AI ...

The world's highest-profile and most watched awards show, which has aired on ABC since 1976, will be moving to a streaming-only platform starting as part of a deal that also includes red carpet ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

You aren’t just one thing, and neither is your watch history. Maybe 2025 was your custom keyboard era, or when you became KATSEYE’s biggest fan, or watched a ton of Labubu blind box reveals. More ...

Summary I now rate Recursion Pharma a sell due to disappointing recent trial updates and uncertain future prospects. REC-4881's phase 2 TUPELO trial showed mixed results, with one patient experiencing ...

NEW YORK – May 27, 2025 – YouTube maintained its lead among media companies in Nielsen’s April 2025 Media Distributor Gauge report, representing 12.4% of audiences’ time spent watching television.

Java Development Kit (JDK) 24 is now available as a production release. A short-term support release of standard Java, JDK 24 will receive only six months of Premier-level support from Oracle, ...

SALT LAKE CITY, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...

Nvidia exited its positions in several AI stocks in Q4, but maintained its stake in Recursion Pharmaceuticals. Many investors seemed to view this as a vote of confidence from Nvidia for Recursion. The ...

Najat Khan, PhD, Recursion Pharmaceuticals chief R&D officer and chief commercial officer With at least seven of its programs expected to begin human trials or read out clinical data during 2025, ...